Search results
Results from the WOW.Com Content Network
B: Better symptom and atrial fibrillation management with patient-centred, symptom directed decisions on rate control or rhythm control. In some selected patients, use early rhythm control may be beneficial. C: Cardiovascular risk factor and comorbidity management, including attention to lifestyle factors and psychological morbidity.
Meaning ā (a with a bar over it) before (from Latin ante) before: A: assessment a.a. of each (from Latin ana ana) amino acids: A or Ala – alanine; C or Cys – cysteine; D or Asp – aspartic acid; E or Glu – glutamic acid; F or Phe – phenylalanine; H or His – histidine; I or Ile – isoleucine; K or Lys – lysine; L or Leu ...
Pronunciation follows convention outside the medical field, in which acronyms are generally pronounced as if they were a word (JAMA, SIDS), initialisms are generally pronounced as individual letters (DNA, SSRI), and abbreviations generally use the expansion (soln. = "solution", sup. = "superior").
Apnea testing is not suitable in patients who are hemodynamically unstable with increasing vasopressor needs, metabolic acidosis, or require high levels of ventilatory support. Apnea testing carries the risk of arrhythmias, worsening hemodynamic instability, or metabolic acidosis beyond the level of recovery and can potentially make the patient ...
An early warning system (EWS), sometimes called a between-the-flags or track-and-trigger chart, is a clinical tool used in healthcare to anticipate patient deterioration by measuring the cumulative variation in observations, most often being patient vital signs and level of consciousness. [1]
The concept of implied consent can protect first responders in emergency situations. A first responder may not legally touch a patient without the patient's consent. However, consent may be either expressed or implied: [3] If a patient is able to make decisions, they must give expressed, informed consent before aid is given.
This page was last edited on 19 January 2013, at 16:51 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
In pharmaceuticals, an adverse event (AE) is any unexpected or harmful medical occurrence that happens to a patient during medical treatment or a clinical trial. Unlike direct side effects, an adverse event does not necessarily mean the medication directly caused the problem.